FDA in the Twenty-First Century : : The Challenges of Regulating Drugs and New Technologies / / ed. by Holly Fernandez Lynch, I. Glenn Cohen.
In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges...
Saved in:
Superior document: | Title is part of eBook package: De Gruyter Columbia University Press Complete eBook-Package 2014-2015 |
---|---|
MitwirkendeR: | |
HerausgeberIn: | |
Place / Publishing House: | New York, NY : : Columbia University Press, , [2015] ©2015 |
Year of Publication: | 2015 |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (568 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
9780231540070 |
---|---|
ctrlnum |
(DE-B1597)458424 (OCoLC)918969867 |
collection |
bib_alma |
record_format |
marc |
spelling |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / ed. by Holly Fernandez Lynch, I. Glenn Cohen. New York, NY : Columbia University Press, [2015] ©2015 1 online resource (568 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier text file PDF rda Frontmatter -- Contents -- Acknowledgments -- Introduction -- Chapter One. Historical Themes and Developments at FDA Over the Past Fifty Years -- PART ONE. FDA in a Changing World -- Introduction -- Chapter Two. A Global and Innovative Regulatory Environment for the U.S. FDA -- Chapter Three. FDA and the Rise of the Empowered Patient -- Chapter Four. After the FDA -- Chapter Five. The Future of Prospective Medicine Under the Food and Drug Administration Amendments Act of 2007 -- PART TWO. Preserving Public Trust and Demanding Accountability -- Introduction -- Chapter Six. Global Trends Toward Transparency in Participant-Level Clinical Trials Data -- Chapter Seven. Conflicts of Interest in FDA Advisory Committees -- Chapter Eight. The Crime of Being in Charge -- Chapter Nine. Recalibrating Enforcement in the Biomedical Industry -- PART THREE. Protecting the Public Within Constitutional Limits -- Introduction -- Chapter Ten. Prospects for Regulation of Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection -- Chapter Eleven. The FDCA as the Test for Truth of Promotional Claims -- Chapter Twelve. Why FDA’s Ban on Off-Label Promotion Violates the First Amendment -- PART FOUR. Timing Is Everything -- Introduction -- Chapter Thirteen. Speed Versus Safety in Drug Development -- Chapter Fourteen. Overcoming “Premarket Syndrome” -- Chapter Fifteen. FDA’s Public Health Imperative -- PART FIVE. Old and New Issues in Drug Regulation -- Introduction -- Chapter Sixteen. The Drug Efficacy Study and Its Manifold Legacies -- Chapter Seventeen. Drug Safety Communication -- Chapter Eighteen. Innovation Policy Failures in the Manufacturing of Drugs -- PART SIX. Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars -- Introduction -- Chapter Nineteen. From “Recycled Molecule” to Orphan Drug -- Chapter Twenty. FDA, Negotiated Rulemaking, and Generics -- Chapter Twenty-One. The “Follow-On” Challenge -- Chapter Twenty-Two. FDA Regulation of Biosimilars -- PART SEVEN. New Wine in Old Bottles -- Introduction -- Chapter Twenty-Three. Analog Agency in a Digital World -- Chapter Twenty-Four. Twenty-First-Century Technology with Twentieth-Century Baggage -- Chapter Twenty-Five. Device-ive Maneuvers -- Chapter Twenty-Six. A New Regulatory Function for E-Prescriptions -- Chapter Twenty-Seven. Race and the FDA -- Contributors -- Index restricted access http://purl.org/coar/access_right/c_16ec online access with authorization star In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good.The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad. Mode of access: Internet via World Wide Web. In English. Description based on online resource; title from PDF title page (publisher's Web site, viewed 29. Mai 2023) Drugs Law and legislation United States. BUSINESS & ECONOMICS / Government & Business. bisacsh Barnes, Mark, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Bierer, Barbara, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Boyd, Marie, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Carpenter, Daniel, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Charo, R. Alta, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Cohen, I. Glenn, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Cohen, I. Glenn, editor. edt http://id.loc.gov/vocabulary/relators/edt Copeland, Katrice Bridges, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Cortez, Nathan, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Devine, Jennifer, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Digilova, Alla, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb English, Andrew, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Evans, Barbara J., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Gibson, Shannon, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Grabowski, Henry, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Greene, Jeremy, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Greenwood, Kate, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Grossman, Lewis A., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Hutt, Peter Barton, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Kahn, Jonathan, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Kesselheim, Aaron S., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Klasmeier, Coleen, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Lemmens, Trudo, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Levitt, Geoffrey, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Li, Rebecca, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Lietzan, Erika, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Lynch, Holly Fernandez, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Lynch, Holly Fernandez, editor. edt http://id.loc.gov/vocabulary/relators/edt Mello, Michelle M., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Miller, Frances H., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Moffitt, Susan, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb O’Leary, Patrick, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Parasidis, Efthimios, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Pham-Kanter, Genevieve, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Pike, Elizabeth R., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Price, W. Nicholson, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Rai, Arti, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Redish, Martin H., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Riley, Margaret Foster, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Robertson, Christopher, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Roin, Benjamin N., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Rosenberg, David, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Ruger, Theodore W., contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Sklamberg, Howard, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Spector-Bagdady, Kayte, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Yan, Huaou, contributor. ctb https://id.loc.gov/vocabulary/relators/ctb Title is part of eBook package: De Gruyter Columbia University Press Complete eBook-Package 2014-2015 9783110665864 print 9780231171182 https://www.degruyter.com/isbn/9780231540070 Cover https://www.degruyter.com/document/cover/isbn/9780231540070/original |
language |
English |
format |
eBook |
author2 |
Barnes, Mark, Barnes, Mark, Bierer, Barbara, Bierer, Barbara, Boyd, Marie, Boyd, Marie, Carpenter, Daniel, Carpenter, Daniel, Charo, R. Alta, Charo, R. Alta, Cohen, I. Glenn, Cohen, I. Glenn, Cohen, I. Glenn, Cohen, I. Glenn, Copeland, Katrice Bridges, Copeland, Katrice Bridges, Cortez, Nathan, Cortez, Nathan, Devine, Jennifer, Devine, Jennifer, Digilova, Alla, Digilova, Alla, English, Andrew, English, Andrew, Evans, Barbara J., Evans, Barbara J., Gibson, Shannon, Gibson, Shannon, Grabowski, Henry, Grabowski, Henry, Greene, Jeremy, Greene, Jeremy, Greenwood, Kate, Greenwood, Kate, Grossman, Lewis A., Grossman, Lewis A., Hutt, Peter Barton, Hutt, Peter Barton, Kahn, Jonathan, Kahn, Jonathan, Kesselheim, Aaron S., Kesselheim, Aaron S., Klasmeier, Coleen, Klasmeier, Coleen, Lemmens, Trudo, Lemmens, Trudo, Levitt, Geoffrey, Levitt, Geoffrey, Li, Rebecca, Li, Rebecca, Lietzan, Erika, Lietzan, Erika, Lynch, Holly Fernandez, Lynch, Holly Fernandez, Lynch, Holly Fernandez, Lynch, Holly Fernandez, Mello, Michelle M., Mello, Michelle M., Miller, Frances H., Miller, Frances H., Moffitt, Susan, Moffitt, Susan, O’Leary, Patrick, O’Leary, Patrick, Parasidis, Efthimios, Parasidis, Efthimios, Pham-Kanter, Genevieve, Pham-Kanter, Genevieve, Pike, Elizabeth R., Pike, Elizabeth R., Price, W. Nicholson, Price, W. Nicholson, Rai, Arti, Rai, Arti, Redish, Martin H., Redish, Martin H., Riley, Margaret Foster, Riley, Margaret Foster, Robertson, Christopher, Robertson, Christopher, Roin, Benjamin N., Roin, Benjamin N., Rosenberg, David, Rosenberg, David, Ruger, Theodore W., Ruger, Theodore W., Sklamberg, Howard, Sklamberg, Howard, Spector-Bagdady, Kayte, Spector-Bagdady, Kayte, Yan, Huaou, Yan, Huaou, |
author_facet |
Barnes, Mark, Barnes, Mark, Bierer, Barbara, Bierer, Barbara, Boyd, Marie, Boyd, Marie, Carpenter, Daniel, Carpenter, Daniel, Charo, R. Alta, Charo, R. Alta, Cohen, I. Glenn, Cohen, I. Glenn, Cohen, I. Glenn, Cohen, I. Glenn, Copeland, Katrice Bridges, Copeland, Katrice Bridges, Cortez, Nathan, Cortez, Nathan, Devine, Jennifer, Devine, Jennifer, Digilova, Alla, Digilova, Alla, English, Andrew, English, Andrew, Evans, Barbara J., Evans, Barbara J., Gibson, Shannon, Gibson, Shannon, Grabowski, Henry, Grabowski, Henry, Greene, Jeremy, Greene, Jeremy, Greenwood, Kate, Greenwood, Kate, Grossman, Lewis A., Grossman, Lewis A., Hutt, Peter Barton, Hutt, Peter Barton, Kahn, Jonathan, Kahn, Jonathan, Kesselheim, Aaron S., Kesselheim, Aaron S., Klasmeier, Coleen, Klasmeier, Coleen, Lemmens, Trudo, Lemmens, Trudo, Levitt, Geoffrey, Levitt, Geoffrey, Li, Rebecca, Li, Rebecca, Lietzan, Erika, Lietzan, Erika, Lynch, Holly Fernandez, Lynch, Holly Fernandez, Lynch, Holly Fernandez, Lynch, Holly Fernandez, Mello, Michelle M., Mello, Michelle M., Miller, Frances H., Miller, Frances H., Moffitt, Susan, Moffitt, Susan, O’Leary, Patrick, O’Leary, Patrick, Parasidis, Efthimios, Parasidis, Efthimios, Pham-Kanter, Genevieve, Pham-Kanter, Genevieve, Pike, Elizabeth R., Pike, Elizabeth R., Price, W. Nicholson, Price, W. Nicholson, Rai, Arti, Rai, Arti, Redish, Martin H., Redish, Martin H., Riley, Margaret Foster, Riley, Margaret Foster, Robertson, Christopher, Robertson, Christopher, Roin, Benjamin N., Roin, Benjamin N., Rosenberg, David, Rosenberg, David, Ruger, Theodore W., Ruger, Theodore W., Sklamberg, Howard, Sklamberg, Howard, Spector-Bagdady, Kayte, Spector-Bagdady, Kayte, Yan, Huaou, Yan, Huaou, |
author2_variant |
m b mb m b mb b b bb b b bb m b mb m b mb d c dc d c dc r a c ra rac r a c ra rac i g c ig igc i g c ig igc i g c ig igc i g c ig igc k b c kb kbc k b c kb kbc n c nc n c nc j d jd j d jd a d ad a d ad a e ae a e ae b j e bj bje b j e bj bje s g sg s g sg h g hg h g hg j g jg j g jg k g kg k g kg l a g la lag l a g la lag p b h pb pbh p b h pb pbh j k jk j k jk a s k as ask a s k as ask c k ck c k ck t l tl t l tl g l gl g l gl r l rl r l rl e l el e l el h f l hf hfl h f l hf hfl h f l hf hfl h f l hf hfl m m m mm mmm m m m mm mmm f h m fh fhm f h m fh fhm s m sm s m sm p o po p o po e p ep e p ep g p k gpk g p k gpk e r p er erp e r p er erp w n p wn wnp w n p wn wnp a r ar a r ar m h r mh mhr m h r mh mhr m f r mf mfr m f r mf mfr c r cr c r cr b n r bn bnr b n r bn bnr d r dr d r dr t w r tw twr t w r tw twr h s hs h s hs k s b ksb k s b ksb h y hy h y hy |
author2_role |
MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR HerausgeberIn HerausgeberIn MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR HerausgeberIn HerausgeberIn MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR MitwirkendeR |
author_sort |
Barnes, Mark, |
title |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / |
spellingShingle |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / Frontmatter -- Contents -- Acknowledgments -- Introduction -- Chapter One. Historical Themes and Developments at FDA Over the Past Fifty Years -- PART ONE. FDA in a Changing World -- Chapter Two. A Global and Innovative Regulatory Environment for the U.S. FDA -- Chapter Three. FDA and the Rise of the Empowered Patient -- Chapter Four. After the FDA -- Chapter Five. The Future of Prospective Medicine Under the Food and Drug Administration Amendments Act of 2007 -- PART TWO. Preserving Public Trust and Demanding Accountability -- Chapter Six. Global Trends Toward Transparency in Participant-Level Clinical Trials Data -- Chapter Seven. Conflicts of Interest in FDA Advisory Committees -- Chapter Eight. The Crime of Being in Charge -- Chapter Nine. Recalibrating Enforcement in the Biomedical Industry -- PART THREE. Protecting the Public Within Constitutional Limits -- Chapter Ten. Prospects for Regulation of Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection -- Chapter Eleven. The FDCA as the Test for Truth of Promotional Claims -- Chapter Twelve. Why FDA’s Ban on Off-Label Promotion Violates the First Amendment -- PART FOUR. Timing Is Everything -- Chapter Thirteen. Speed Versus Safety in Drug Development -- Chapter Fourteen. Overcoming “Premarket Syndrome” -- Chapter Fifteen. FDA’s Public Health Imperative -- PART FIVE. Old and New Issues in Drug Regulation -- Chapter Sixteen. The Drug Efficacy Study and Its Manifold Legacies -- Chapter Seventeen. Drug Safety Communication -- Chapter Eighteen. Innovation Policy Failures in the Manufacturing of Drugs -- PART SIX. Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars -- Chapter Nineteen. From “Recycled Molecule” to Orphan Drug -- Chapter Twenty. FDA, Negotiated Rulemaking, and Generics -- Chapter Twenty-One. The “Follow-On” Challenge -- Chapter Twenty-Two. FDA Regulation of Biosimilars -- PART SEVEN. New Wine in Old Bottles -- Chapter Twenty-Three. Analog Agency in a Digital World -- Chapter Twenty-Four. Twenty-First-Century Technology with Twentieth-Century Baggage -- Chapter Twenty-Five. Device-ive Maneuvers -- Chapter Twenty-Six. A New Regulatory Function for E-Prescriptions -- Chapter Twenty-Seven. Race and the FDA -- Contributors -- Index |
title_sub |
The Challenges of Regulating Drugs and New Technologies / |
title_full |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / ed. by Holly Fernandez Lynch, I. Glenn Cohen. |
title_fullStr |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / ed. by Holly Fernandez Lynch, I. Glenn Cohen. |
title_full_unstemmed |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / ed. by Holly Fernandez Lynch, I. Glenn Cohen. |
title_auth |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / |
title_alt |
Frontmatter -- Contents -- Acknowledgments -- Introduction -- Chapter One. Historical Themes and Developments at FDA Over the Past Fifty Years -- PART ONE. FDA in a Changing World -- Chapter Two. A Global and Innovative Regulatory Environment for the U.S. FDA -- Chapter Three. FDA and the Rise of the Empowered Patient -- Chapter Four. After the FDA -- Chapter Five. The Future of Prospective Medicine Under the Food and Drug Administration Amendments Act of 2007 -- PART TWO. Preserving Public Trust and Demanding Accountability -- Chapter Six. Global Trends Toward Transparency in Participant-Level Clinical Trials Data -- Chapter Seven. Conflicts of Interest in FDA Advisory Committees -- Chapter Eight. The Crime of Being in Charge -- Chapter Nine. Recalibrating Enforcement in the Biomedical Industry -- PART THREE. Protecting the Public Within Constitutional Limits -- Chapter Ten. Prospects for Regulation of Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection -- Chapter Eleven. The FDCA as the Test for Truth of Promotional Claims -- Chapter Twelve. Why FDA’s Ban on Off-Label Promotion Violates the First Amendment -- PART FOUR. Timing Is Everything -- Chapter Thirteen. Speed Versus Safety in Drug Development -- Chapter Fourteen. Overcoming “Premarket Syndrome” -- Chapter Fifteen. FDA’s Public Health Imperative -- PART FIVE. Old and New Issues in Drug Regulation -- Chapter Sixteen. The Drug Efficacy Study and Its Manifold Legacies -- Chapter Seventeen. Drug Safety Communication -- Chapter Eighteen. Innovation Policy Failures in the Manufacturing of Drugs -- PART SIX. Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars -- Chapter Nineteen. From “Recycled Molecule” to Orphan Drug -- Chapter Twenty. FDA, Negotiated Rulemaking, and Generics -- Chapter Twenty-One. The “Follow-On” Challenge -- Chapter Twenty-Two. FDA Regulation of Biosimilars -- PART SEVEN. New Wine in Old Bottles -- Chapter Twenty-Three. Analog Agency in a Digital World -- Chapter Twenty-Four. Twenty-First-Century Technology with Twentieth-Century Baggage -- Chapter Twenty-Five. Device-ive Maneuvers -- Chapter Twenty-Six. A New Regulatory Function for E-Prescriptions -- Chapter Twenty-Seven. Race and the FDA -- Contributors -- Index |
title_new |
FDA in the Twenty-First Century : |
title_sort |
fda in the twenty-first century : the challenges of regulating drugs and new technologies / |
publisher |
Columbia University Press, |
publishDate |
2015 |
physical |
1 online resource (568 p.) |
contents |
Frontmatter -- Contents -- Acknowledgments -- Introduction -- Chapter One. Historical Themes and Developments at FDA Over the Past Fifty Years -- PART ONE. FDA in a Changing World -- Chapter Two. A Global and Innovative Regulatory Environment for the U.S. FDA -- Chapter Three. FDA and the Rise of the Empowered Patient -- Chapter Four. After the FDA -- Chapter Five. The Future of Prospective Medicine Under the Food and Drug Administration Amendments Act of 2007 -- PART TWO. Preserving Public Trust and Demanding Accountability -- Chapter Six. Global Trends Toward Transparency in Participant-Level Clinical Trials Data -- Chapter Seven. Conflicts of Interest in FDA Advisory Committees -- Chapter Eight. The Crime of Being in Charge -- Chapter Nine. Recalibrating Enforcement in the Biomedical Industry -- PART THREE. Protecting the Public Within Constitutional Limits -- Chapter Ten. Prospects for Regulation of Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection -- Chapter Eleven. The FDCA as the Test for Truth of Promotional Claims -- Chapter Twelve. Why FDA’s Ban on Off-Label Promotion Violates the First Amendment -- PART FOUR. Timing Is Everything -- Chapter Thirteen. Speed Versus Safety in Drug Development -- Chapter Fourteen. Overcoming “Premarket Syndrome” -- Chapter Fifteen. FDA’s Public Health Imperative -- PART FIVE. Old and New Issues in Drug Regulation -- Chapter Sixteen. The Drug Efficacy Study and Its Manifold Legacies -- Chapter Seventeen. Drug Safety Communication -- Chapter Eighteen. Innovation Policy Failures in the Manufacturing of Drugs -- PART SIX. Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars -- Chapter Nineteen. From “Recycled Molecule” to Orphan Drug -- Chapter Twenty. FDA, Negotiated Rulemaking, and Generics -- Chapter Twenty-One. The “Follow-On” Challenge -- Chapter Twenty-Two. FDA Regulation of Biosimilars -- PART SEVEN. New Wine in Old Bottles -- Chapter Twenty-Three. Analog Agency in a Digital World -- Chapter Twenty-Four. Twenty-First-Century Technology with Twentieth-Century Baggage -- Chapter Twenty-Five. Device-ive Maneuvers -- Chapter Twenty-Six. A New Regulatory Function for E-Prescriptions -- Chapter Twenty-Seven. Race and the FDA -- Contributors -- Index |
isbn |
9780231540070 9783110665864 9780231171182 |
callnumber-first |
K - Law |
callnumber-subject |
KF - United States |
callnumber-label |
KF3871 |
callnumber-sort |
KF 43871 F34 42016 |
geographic_facet |
United States. |
url |
https://www.degruyter.com/isbn/9780231540070 https://www.degruyter.com/document/cover/isbn/9780231540070/original |
illustrated |
Not Illustrated |
oclc_num |
918969867 |
work_keys_str_mv |
AT barnesmark fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT biererbarbara fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT boydmarie fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT carpenterdaniel fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT charoralta fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT coheniglenn fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT copelandkatricebridges fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT corteznathan fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT devinejennifer fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT digilovaalla fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT englishandrew fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT evansbarbaraj fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT gibsonshannon fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT grabowskihenry fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT greenejeremy fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT greenwoodkate fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT grossmanlewisa fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT huttpeterbarton fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT kahnjonathan fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT kesselheimaarons fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT klasmeiercoleen fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT lemmenstrudo fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT levittgeoffrey fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT lirebecca fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT lietzanerika fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT lynchhollyfernandez fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT mellomichellem fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT millerfrancesh fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT moffittsusan fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT olearypatrick fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT parasidisefthimios fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT phamkantergenevieve fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT pikeelizabethr fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT pricewnicholson fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT raiarti fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT redishmartinh fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT rileymargaretfoster fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT robertsonchristopher fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT roinbenjaminn fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT rosenbergdavid fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT rugertheodorew fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT sklamberghoward fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT spectorbagdadykayte fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies AT yanhuaou fdainthetwentyfirstcenturythechallengesofregulatingdrugsandnewtechnologies |
status_str |
n |
ids_txt_mv |
(DE-B1597)458424 (OCoLC)918969867 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Title is part of eBook package: De Gruyter Columbia University Press Complete eBook-Package 2014-2015 |
is_hierarchy_title |
FDA in the Twenty-First Century : The Challenges of Regulating Drugs and New Technologies / |
container_title |
Title is part of eBook package: De Gruyter Columbia University Press Complete eBook-Package 2014-2015 |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1770176063006048256 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>10701nam a22012255i 4500</leader><controlfield tag="001">9780231540070</controlfield><controlfield tag="003">DE-B1597</controlfield><controlfield tag="005">20230529094047.0</controlfield><controlfield tag="006">m|||||o||d||||||||</controlfield><controlfield tag="007">cr || ||||||||</controlfield><controlfield tag="008">230529t20152015nyu fo d z eng d</controlfield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">(OCoLC)979969566</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780231540070</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-B1597)458424</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)918969867</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-B1597</subfield><subfield code="b">eng</subfield><subfield code="c">DE-B1597</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">nyu</subfield><subfield code="c">US-NY</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">KF3871</subfield><subfield code="b">.F34 2016</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">BUS079000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">FDA in the Twenty-First Century :</subfield><subfield code="b">The Challenges of Regulating Drugs and New Technologies /</subfield><subfield code="c">ed. by Holly Fernandez Lynch, I. Glenn Cohen.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY : </subfield><subfield code="b">Columbia University Press, </subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (568 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="a">text file</subfield><subfield code="b">PDF</subfield><subfield code="2">rda</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="t">Frontmatter -- </subfield><subfield code="t">Contents -- </subfield><subfield code="t">Acknowledgments -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter One. Historical Themes and Developments at FDA Over the Past Fifty Years -- </subfield><subfield code="t">PART ONE. FDA in a Changing World -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Two. A Global and Innovative Regulatory Environment for the U.S. FDA -- </subfield><subfield code="t">Chapter Three. FDA and the Rise of the Empowered Patient -- </subfield><subfield code="t">Chapter Four. After the FDA -- </subfield><subfield code="t">Chapter Five. The Future of Prospective Medicine Under the Food and Drug Administration Amendments Act of 2007 -- </subfield><subfield code="t">PART TWO. Preserving Public Trust and Demanding Accountability -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Six. Global Trends Toward Transparency in Participant-Level Clinical Trials Data -- </subfield><subfield code="t">Chapter Seven. Conflicts of Interest in FDA Advisory Committees -- </subfield><subfield code="t">Chapter Eight. The Crime of Being in Charge -- </subfield><subfield code="t">Chapter Nine. Recalibrating Enforcement in the Biomedical Industry -- </subfield><subfield code="t">PART THREE. Protecting the Public Within Constitutional Limits -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Ten. Prospects for Regulation of Off-Label Drug Promotion in an Era of Expanding Commercial Speech Protection -- </subfield><subfield code="t">Chapter Eleven. The FDCA as the Test for Truth of Promotional Claims -- </subfield><subfield code="t">Chapter Twelve. Why FDA’s Ban on Off-Label Promotion Violates the First Amendment -- </subfield><subfield code="t">PART FOUR. Timing Is Everything -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Thirteen. Speed Versus Safety in Drug Development -- </subfield><subfield code="t">Chapter Fourteen. Overcoming “Premarket Syndrome” -- </subfield><subfield code="t">Chapter Fifteen. FDA’s Public Health Imperative -- </subfield><subfield code="t">PART FIVE. Old and New Issues in Drug Regulation -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Sixteen. The Drug Efficacy Study and Its Manifold Legacies -- </subfield><subfield code="t">Chapter Seventeen. Drug Safety Communication -- </subfield><subfield code="t">Chapter Eighteen. Innovation Policy Failures in the Manufacturing of Drugs -- </subfield><subfield code="t">PART SIX. Regulatory Exclusivities and the Regulation of Generic Drugs and Biosimilars -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Nineteen. From “Recycled Molecule” to Orphan Drug -- </subfield><subfield code="t">Chapter Twenty. FDA, Negotiated Rulemaking, and Generics -- </subfield><subfield code="t">Chapter Twenty-One. The “Follow-On” Challenge -- </subfield><subfield code="t">Chapter Twenty-Two. FDA Regulation of Biosimilars -- </subfield><subfield code="t">PART SEVEN. New Wine in Old Bottles -- </subfield><subfield code="t">Introduction -- </subfield><subfield code="t">Chapter Twenty-Three. Analog Agency in a Digital World -- </subfield><subfield code="t">Chapter Twenty-Four. Twenty-First-Century Technology with Twentieth-Century Baggage -- </subfield><subfield code="t">Chapter Twenty-Five. Device-ive Maneuvers -- </subfield><subfield code="t">Chapter Twenty-Six. A New Regulatory Function for E-Prescriptions -- </subfield><subfield code="t">Chapter Twenty-Seven. Race and the FDA -- </subfield><subfield code="t">Contributors -- </subfield><subfield code="t">Index</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">restricted access</subfield><subfield code="u">http://purl.org/coar/access_right/c_16ec</subfield><subfield code="f">online access with authorization</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In its decades-long effort to assure the safety, efficacy, and security of medicines and other products, the Food and Drug Administration has struggled with issues of funding, proper associations with industry, and the balance between consumer choice and consumer protection. Today, these challenges are compounded by the pressures of globalization, the introduction of novel technologies, and fast-evolving threats to public health. With essays by leading scholars and government and private-industry experts, FDA in the Twenty-First Century addresses perennial and new problems and the improvements the agency can make to better serve the public good.The collection features essays on effective regulation in an era of globalization, consumer empowerment, and comparative effectiveness, as well as questions of data transparency, conflicts of interest, industry responsibility, and innovation policy, all with an emphasis on pharmaceuticals. The book also intervenes in the debate over off-label drug marketing and the proper role of the FDA before and after a drug goes on the market. Dealing honestly and thoroughly with the FDA's successes and failures, these essays rethink the structure, function, and future of the agency and the effect policy innovations may have on regulatory institutions abroad.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Mode of access: Internet via World Wide Web.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 29. Mai 2023)</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Law and legislation</subfield><subfield code="z">United States.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BUSINESS & ECONOMICS / Government & Business.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Barnes, Mark, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bierer, Barbara, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Boyd, Marie, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carpenter, Daniel, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Charo, R. Alta, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, I. Glenn, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, I. Glenn, </subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Copeland, Katrice Bridges, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cortez, Nathan, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Devine, Jennifer, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Digilova, Alla, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Andrew, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Evans, Barbara J., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gibson, Shannon, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grabowski, Henry, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Greene, Jeremy, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Greenwood, Kate, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grossman, Lewis A., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hutt, Peter Barton, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kahn, Jonathan, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kesselheim, Aaron S., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klasmeier, Coleen, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lemmens, Trudo, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levitt, Geoffrey, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Rebecca, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lietzan, Erika, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lynch, Holly Fernandez, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lynch, Holly Fernandez, </subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mello, Michelle M., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Miller, Frances H., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moffitt, Susan, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O’Leary, Patrick, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parasidis, Efthimios, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pham-Kanter, Genevieve, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pike, Elizabeth R., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Price, W. Nicholson, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rai, Arti, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Redish, Martin H., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Riley, Margaret Foster, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robertson, Christopher, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roin, Benjamin N., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosenberg, David, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruger, Theodore W., </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sklamberg, Howard, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Spector-Bagdady, Kayte, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yan, Huaou, </subfield><subfield code="e">contributor.</subfield><subfield code="4">ctb</subfield><subfield code="4">https://id.loc.gov/vocabulary/relators/ctb</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Title is part of eBook package:</subfield><subfield code="d">De Gruyter</subfield><subfield code="t">Columbia University Press Complete eBook-Package 2014-2015</subfield><subfield code="z">9783110665864</subfield></datafield><datafield tag="776" ind1="0" ind2=" "><subfield code="c">print</subfield><subfield code="z">9780231171182</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.degruyter.com/isbn/9780231540070</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="3">Cover</subfield><subfield code="u">https://www.degruyter.com/document/cover/isbn/9780231540070/original</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">978-3-11-066586-4 Columbia University Press Complete eBook-Package 2014-2015</subfield><subfield code="c">2014</subfield><subfield code="d">2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_BACKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_CL_LAEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EBACKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EBKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_ECL_LAEC</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_EEBKALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_ESSHALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_ESTMALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_PPALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_SSHALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">EBA_STMALL</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV-deGruyter-alles</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA11SSHE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA12STME</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA13ENGE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA17SSHEE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA18STMEE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">PDA5EBK</subfield></datafield></record></collection> |